Skip to main content
. 2020 Jan 31;30(5):2680–2691. doi: 10.1007/s00330-019-06597-8

Table 1.

Demographic and clinical characteristics of patients on different datasets

Variable Training (n = 331) Testing (n = 143) Validation (n = 149) p value
Age, n (%)
  ≤ 60 172 (52.0) 74 (51.7) 67 (45.0) 0.34
  > 60 159 (48.0) 69 (48.3) 82 (55.0)
Gender, n (%)
  Male 111 (33.5) 45 (31.5) 62 (41.6) 0.14
  Female 220 (66.5) 98 (68.5) 87 (58.4)
Smoking, n (%)
  Yes 46 (13.9) 19 (13.3) 30 (20.1) 0.16
  No 285 (86.1) 124 (86.7) 119 (79.9)
Family history, n (%)
  Yes 9 (2.7) 6 (4.2) 7 (4.7) 0.49
  No 322 (97.3) 137 (95.8) 142 (95.3)
Final pathology, n (%)
  IA 200 (60.4) 86 (60.1) 105 (70.5) 0.08
  PM 131 (39.6) 57 (39.9) 44 (29.5)
Diameter (cm), n (%)
  ≤ 1 132 (39.9) 54 (37.8) 52 (34.9) 0.54
  1.1–2.0 131 (39.6) 51 (35.7) 63 (42.3)
  2.1–3.0 68 (20.5) 38 (26.6) 34 (22.8)
Location, n (%)
  LUL 78 (23.6) 31 (21.7) 26 (17.4) 0.37
  LLL 49 (14.8) 28 (19.6) 22 (14.8)
  RUL 127 (38.4) 51 (35.7) 51 (34.2)
  RML 23 (6.9) 10 (7.0) 14 (9.4)
  RLL 54 (16.3) 23 (16.1) 36 (24.2)
Nodule type, n (%)
  pGGN 124 (37.5) 49 (34.3) 37 (24.8) 0.09
  PSN 150 (45.3) 71 (49.7) 79 (53.0)
  Solid 57 (17.2) 23 (16.1) 33 (22.1)
  Volume (mm3), n (%)
  < 500 115 (34.7) 47 (32.9) 43 (28.9) 0.60
  500–1000 67 (20.2) 29 (20.3) 27 (18.1)
  > 1000 149 (45.0) 67 (46.9) 79 (53.0)
Surgical type, n (%)
  Lobectomy 256 (77.3) 103 (72.0) 104 (69.8) 0.17
  Limited resection 75 (22.7) 40 (28.0) 45 (30.2)

IA, invasive adenocarcinoma; PM, preinvasive lesions/minimally invasive adenocarcinomas; LUL, left upper lobe; LLL, left lower lobe; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; pGGN, pure ground-glass nodule; PSN, part-solid nodule. p values calculated using Pearson’s chi-squared test